Navigation Links
Dana-Farber/Provenge: Approval of prostate cancer immunotherapy-new era of cancer treatments
Date:4/29/2010

BOSTONToday's announcement that the U.S. Food and Drug Administration has approved Provenge, a new form of therapy for some prostate cancer patients, marks the beginning of an era in which patients' own immune systems become part of the standard therapeutic arsenal against cancer, say Dana-Farber Cancer Institute investigators who led a study of the treatment's effectiveness in patients.

The study the results of which were presented most recently at the 2010 Genitourinary American Society of Clinical Oncology's annual meeting is the first large, controlled clinical trial to show that an immune system-based therapy can extend the lives of cancer patients, according to the trial's leader, Philip Kantoff, MD, of Dana-Farber.

"For more than 20 years, scientists have been working on harnessing the immune system in a way that has beneficial effects for cancer patients, notably the prolongation of survival," Kantoff said. "Our study provides proof that such an approach can work."

Unlike preventive vaccines, which bolster the immune system to protect people from contracting an illness, Provenge is an "autologous cellular immunotherapy," or a therapeutic vaccine, that marshals the immune system's disease-fighting forces for people who already have prostate cancer.

The immunotherapy is produced by removing some of a patient's white blood cells a process called leukapheresis and then exposing them to a protein from prostate cancer cells and a stimulatory molecule. The process primes the white blood cells to stimulate the immune system and attack prostate cancer when they are re-injected into the body.

The clinical study, a Phase III trial conducted at cancer treatment centers across the country, enrolled 512 patients with advanced prostate cancer that had spread beyond the prostate gland and that grew even when deprived of the hormone androgen, a condition known as metastatic hormone-resistant prostate cancer. Patients
'/>"/>

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-5653
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy
2. Prostate Cancer Vaccine Gains FDA Approval
3. Third European Novel Food Approval Received by Tahitian Noni International
4. Prostate Cancer Vaccine May Get FDA Approval
5. Almac to Improve Label Approval Process in Clinical Trials
6. Mega Stock Picks (megastockpicks.com) Initiates Coverage on FDA Approval for POZEN, Inc.(NasdaqGM: POZN) Drug Vimovo with Immediate Buy Recommendation
7. Yondelis(R) Receives Five New Approvals Outside the European Economic Area
8. Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala
9. Physician calls for more rigorous standards for drugs up for FDA approval
10. Approval of Kansas Smoke-Free Legislation Is Historic Win for Health
11. FDA Cancer Drug Approval Rate Highlighted in JNCI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... Efficient Operation for Gateway Healthcare , , PROVIDENCE, ... announced today that it is addressing the complex ... with the unique, next generation voice product, Cox Business ... its telecommunications services from a competitive provider to Cox ...
... marrow registry is free June 8-22; The Jeff Gordon Foundation seeds ... , MINNEAPOLIS, June 8 Every day, thousands of people ... Registry for a bone marrow match. To highlight the enormous need ... , the new name for the National Marrow Donor Program(R) Registry, ...
... ... market today, is now available to more doctors and health care professionals in Missouri through ... ... non-invasive and oral-based lead testing product in the market today, is now available to more ...
... ... sensors sizes up to 1.3 - inch format. , ... Van Nuys, CA (PRWEB) June 8, 2009 -- Schneider Optics, a ... 24mm lens. This is the third new machine vision lens Schneider has introduced in 2009. ...
... under-represented in clinical cancer research published in high-impact journals, ... University of Michigan Comprehensive Cancer Center. Taking into ... women, studies included a smaller proportion of women than ... of cancer types that were not gender specific, including ...
... Perinatology as a Medical Specialty , , WHITE PLAINS, N.Y. ... the United States and worldwide has been seen through the eyes ... evaluate an infant,s health at birth. , , Yesterday marked ... of Dimes, the organization she worked for from 1959 until her ...
Cached Medicine News:Health News:Cox Business Addresses Complex Voice Needs of Health Care Organization 2Health News:Cox Business Addresses Complex Voice Needs of Health Care Organization 3Health News:Cox Business Addresses Complex Voice Needs of Health Care Organization 4Health News:National Marrowthon Campaign Aims to Bring Nearly 50,000 to the Be The Match Registry(SM) in Two Weeks 2Health News:National Marrowthon Campaign Aims to Bring Nearly 50,000 to the Be The Match Registry(SM) in Two Weeks 3Health News:National Marrowthon Campaign Aims to Bring Nearly 50,000 to the Be The Match Registry(SM) in Two Weeks 4Health News:Parents in Missouri Can Now Test Their Children for Lead Exposure Using Saliva 2Health News:Parents in Missouri Can Now Test Their Children for Lead Exposure Using Saliva 3Health News:Parents in Missouri Can Now Test Their Children for Lead Exposure Using Saliva 4Health News:Schneider Introduces APO-Xenoplan 2.0/24mm Lens, Specially Designed for Kodak 4 MP Sensors Having Microlenses 2Health News:Schneider Introduces APO-Xenoplan 2.0/24mm Lens, Specially Designed for Kodak 4 MP Sensors Having Microlenses 3Health News:Schneider Introduces APO-Xenoplan 2.0/24mm Lens, Specially Designed for Kodak 4 MP Sensors Having Microlenses 4Health News:Women under-represented in cancer research, U-M study finds 2Health News:March of Dimes Honors 100th Anniversary of Virginia Apgar 2Health News:March of Dimes Honors 100th Anniversary of Virginia Apgar 3
(Date:1/23/2015)... GAINESVILLE, Fla. , Jan. 23, 2015  HyGreen, Inc., ... distribution agreement and partnership with RCA Medical, a subsidiary ... Africa . Each year, hundreds of ... health care-associated infections as organisms are transmitted from patient ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
(Date:1/23/2015)... 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a critical ... adsorber to reduce deadly inflammation in critically-ill and ... net of transaction costs, in non-dilutive funding as ... Certificate Transfer Program sponsored by the New Jersey ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... HAIKOU, China, May 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma ... Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical ... Financial Officer, Mr. Frank Waung, has been invited to ... in New York City on May 17, 2011. Conference ...
... China, May 13, 2011 /PRNewswire-Asia/ -- Winner Medical Group ... leading manufacturer of medical dressings, medical disposables and non-woven ... today announced it will attend the Oppenheimer 5th Annual ... NY. Winner Medical will present on Tuesday, May 17th ...
Cached Medicine Technology:China Pharma Holdings, Inc. to Present at the Eighth Annual Piper Jaffray China Growth Conference in New York on May 17, 2011 2Winner Medical to Present at Oppenheimer 5th Annual China Dragon Conference 2Winner Medical to Present at Oppenheimer 5th Annual China Dragon Conference 3
... articulation maintains full inter-changeability. Modular tibial components ... fit. The Maxim Knee system is ... with expanded options to address surgeon preferences ... for use in total knee replacements both ...
Tibial distractor...
Simple, stable knee positioning triangles for lower extremity surgery. The triangles are radiolucent, autoclavable, and use latex-free, sterile, disposable pads....
... Cemex features a unique self-contained ... clinically proven in Europe for ... integrating bone cement powder and ... system, Cemex is designed to ...
Medicine Products: